CVS Health Corporation (FRA:CVS)
Germany flag Germany · Delayed Price · Currency is EUR
58.81
-0.69 (-1.16%)
At close: May 7, 2025, 10:00 PM CET

CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of EUR 76.12 billion. The enterprise value is 137.09 billion.

Market Cap 76.12B
Enterprise Value 137.09B

Important Dates

The last earnings date was Thursday, May 1, 2025.

Earnings Date May 1, 2025
Ex-Dividend Date Apr 22, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -1.77%
Shares Change (QoQ) +0.24%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 1.26B

Valuation Ratios

The trailing PE ratio is 15.58.

PE Ratio 15.58
Forward PE n/a
PS Ratio 0.22
PB Ratio 1.07
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.12, with an EV/FCF ratio of 24.94.

EV / Earnings 28.06
EV / Sales 0.41
EV / EBITDA 9.12
EV / EBIT 16.56
EV / FCF 24.94

Financial Position

The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.05.

Current Ratio 0.82
Quick Ratio 0.59
Debt / Equity 1.05
Debt / EBITDA 4.79
Debt / FCF 13.67
Interest Coverage 3.08

Financial Efficiency

Return on equity (ROE) is 6.93% and return on invested capital (ROIC) is 3.71%.

Return on Equity (ROE) 6.93%
Return on Assets (ROA) 2.31%
Return on Invested Capital (ROIC) 3.71%
Return on Capital Employed (ROCE) 5.60%
Revenue Per Employee 1.34M
Profits Per Employee 18,825
Employee Count 300,000
Asset Turnover 1.49
Inventory Turnover 19.31

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +11.59% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +11.59%
50-Day Moving Average 60.32
200-Day Moving Average 54.86
Relative Strength Index (RSI) 50.05
Average Volume (20 Days) 396

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 1.74

Income Statement

In the last 12 months, CVS Health had revenue of EUR 348.56 billion and earned 4.89 billion in profits. Earnings per share was 3.88.

Revenue 348.56B
Gross Profit 47.20B
Operating Income 8.64B
Pretax Income 6.65B
Net Income 4.89B
EBITDA 12.90B
EBIT 8.64B
Earnings Per Share (EPS) 3.88
Full Income Statement

Balance Sheet

The company has 11.71 billion in cash and 75.14 billion in debt, giving a net cash position of -63.43 billion.

Cash & Cash Equivalents 11.71B
Total Debt 75.14B
Net Cash -63.43B
Net Cash Per Share n/a
Equity (Book Value) 71.34B
Book Value Per Share 56.40
Working Capital -14.59B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.10 billion and capital expenditures -2.61 billion, giving a free cash flow of 5.50 billion.

Operating Cash Flow 8.10B
Capital Expenditures -2.61B
Free Cash Flow 5.50B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 13.54%, with operating and profit margins of 2.48% and 1.40%.

Gross Margin 13.54%
Operating Margin 2.48%
Pretax Margin 1.91%
Profit Margin 1.40%
EBITDA Margin 3.70%
EBIT Margin 2.48%
FCF Margin 1.58%

Dividends & Yields

This stock pays an annual dividend of 2.44, which amounts to a dividend yield of 4.15%.

Dividend Per Share 2.44
Dividend Yield 4.15%
Dividend Growth (YoY) 3.83%
Years of Dividend Growth 3
Payout Ratio 63.88%
Buyback Yield 1.77%
Shareholder Yield 5.92%
Earnings Yield 6.42%
FCF Yield 7.22%
Dividend Details

Stock Splits

The last stock split was on June 7, 2005. It was a forward split with a ratio of 2.

Last Split Date Jun 7, 2005
Split Type Forward
Split Ratio 2

Scores

CVS Health has an Altman Z-Score of 2.12. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.12
Piotroski F-Score n/a